TPG weighing Pathology Asia stake sale ahead of IPO

TPG asked banks to submit proposals for the potential listing of Pathology Asia in March and was weighing Singapore as an option for the listing venue

SINGAPORE: Private equity firm TPG Capital Asia is exploring selling a stake in its pathology business in the region ahead of a potential initial public offering (IPO) for the unit, according to people with knowledge of the matter.

The buyout firm could sell a 20% stake in Pathology Asia Holdings Pte and is working with advisers on the potential divestment, said the people, who asked not to be identified as the process is private.